一、以9票同意，0票反对，0票弃权，审议通过了《关于出售全资子公司的 进展暨签订<补充协议>的议案》。 内容详见公司于本公告同日在《中国证券报》《证券时报》《上海证券报》 《证券日报》及巨潮资讯网（http://www.cninfo.com.cn）上披露的《关于出售全 资子公司的进展暨签订<补充协议>的公告》（公告编号：2023-039）。 特此公告。 万方城镇投资发展股份有限公司 董 事 会 证券代码：000638 证券简称：万方发展 公告编号：2023-038 万方城镇投资发展股份有限公司 第九届董事会第五十四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 万方城镇投资发展股份有限公司（以下简称"公司"）第九届董事会第五十四 次会议通知于 2023 年 9 月 22 日以通讯形式发出，会议于 2023 年 9 月 26 日下 午 14：30 时在北京市朝阳区裕民路 12 号中国国际科技会展中心 B 座 12A 公司 会议室以通讯的方式召开，会议 ...

证券代码：000638 证券简称：万方发展 公告编号：2023-039 万方城镇投资发展股份有限公司 关于出售全资子公司的进展暨签订《补充协议》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、交易概述 万方城镇投资发展股份有限公司（以下简称"公司"）于 2023 年 6 月 30 日召 开第九届董事会第五十一次会议，审议通过了《关于出售全资子公司的议案》， 公司董事一致同意公司与北京栢裕投资有限公司（以下简称"北京栢裕"）签订《股 权转让协议》，并以人民币 9,000 万元（大写：玖仟万元整）的价格转让公司持有 的北京天源房地产开发有限公司（以下简称"北京天源"或"标的公司"）100%股权。 详见公司于 2023 年 7 月 1 日，在巨潮资讯网（http://www.cninfo.com.cn）披露的 《关于出售全资子公司的公告》（公告编号：2023-025）。 二、本次交易的相关进展 1 / 3 甲方：万方城镇投资发展股份有限公司 乙方：北京栢裕投资有限公司 丙方：北京天源房地产开发有限公司 （一）签订补充协议的情况 1、已履行的审议程序 为了 ...

证券代码：000638 证券简称：万方发展 公告编号：2023-040 万方城镇投资发展股份有限公司 2、股东股份累计被冻结情况 关于股东股份被轮候冻结的公告 本公司及其董事会全体成员保证信息披露内容的真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别风险提示： 万方城镇投资发展股份有限公司（以下简称"公司"）大股东北京万方源房地 产开发有限公司（以下简称"万方源"）累计被冻结股份116,600,000股，占其所持 公司股份数量比例为100%。敬请广大投资者注意投资风险。 公司于近日通过中国证券登记结算有限责任公司系统查询到公司大股东万 方源所持公司部分股份被轮候冻结。具体情况如下： 一、股东股份冻结基本情况 | 股 东 | 是否为控 | | | | 是否为限 | | | | | | 原 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 股股东及 | 本次冻结股 | 占其所持 | 占公司总 | 售股及限 | 起始日 | | 到期日 | | 冻结申请 | | | 名 | 其一致行 | 份数量 ...

证券代码：000638 证券简称：万方发展 公告编号：2023-037 万方城镇投资发展股份有限公司 关于为控股子公司提供担保的公告 本公司及其董事会全体成员保证信息披露内容的真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 截止目前，本次被担保对象湖北新瑞光机电科技有限公司的资产负债率超过 70%，敬请投资者注意投资风险。 一、担保情况概述 1、万方城镇投资发展股份有限公司（以下简称"公司"）于近日与航天科工 金融租赁有限公司（以下简称"债权人"）签署了《航天科工金融租赁有限公司保 证合同》（编号：HTJZ-A(BZ)-2023082-1）。根据上述合同约定，公司为控股子公 司湖北新瑞光机电科技有限公司（以下简称"新瑞光"或"债务人"）与债权人 签署的《融资租赁合同》（编号：HTJZ-A(ZZ)-2023082，以下简称"主合同"）提 供连带责任担保，担保金额为人民币 221 万元，保证期间为主合同项下债务人全 部债务履行期限届满之日起三年。 2、公司于 2023 年 6 月 16 日召开 2022 年年度股东大会审议通过了《关于 2023 年度对外担保额度预计的议案》，公司同意为控股子 ...

Financial Performance - The company's operating revenue for the first half of 2023 was ¥50,029,641.92, a decrease of 13.86% compared to ¥58,080,420.49 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was a loss of ¥9,258,850.13, representing a decline of 23.49% from a loss of ¥7,497,597.76 in the previous year[21]. - The basic and diluted earnings per share were both -¥0.0299, a decrease of 23.55% from -¥0.0242 in the same period last year[22]. - The total revenue from military products increased by 49.51% to ¥8,313,222.23, accounting for 16.62% of total revenue[59]. - Revenue from agricultural products processing and sales decreased by 15.79% to ¥41,215,616.89, representing 82.38% of total revenue[59]. - Total operating revenue for the first half of 2023 was CNY 50,029,641.92, a decrease from CNY 58,080,420.49 in the same period of 2022[162]. - Net loss attributable to shareholders of the parent company was CNY 9,258,850.13 for the first half of 2023, compared to a loss of CNY 7,497,597.76 in the same period of 2022[163]. - Total comprehensive income for the first half of 2023 was -11,928,263.21 yuan, compared to -8,264,461.79 yuan in the same period of 2022, representing a decline of approximately 44.5%[164]. Cash Flow and Liquidity - The net cash flow from operating activities improved to -¥25,134,910.60, a 53.24% increase compared to -¥53,755,985.53 in the same period last year[22]. - The company reported a significant increase in cash flow from investing activities, which improved by 71.46% to -¥10,447,844.03 from -¥36,613,056.63[56]. - The company's cash and cash equivalents decreased by 23.02% to -¥73,905,308.38 from -¥96,002,024.72 year-on-year[57]. - The cash inflow from financing activities was primarily due to 496,881.10 CNY received from investment absorption[171]. - The total cash and cash equivalents decreased by 73,905,308.38 CNY in the first half of 2023, compared to a decrease of 96,002,024.72 CNY in the first half of 2022[169]. - The net cash flow from operating activities for the first half of 2023 was -4,751,796.06 CNY, a significant decline compared to 302,678.89 CNY in the same period of 2022[171]. Assets and Liabilities - The total assets at the end of the reporting period were ¥543,967,522.93, down 4.15% from ¥567,518,095.85 at the end of the previous year[22]. - The company's total liabilities decreased from CNY 339,159,439.91 to CNY 320,478,716.89, a reduction of approximately 5.5%[156]. - The company's current assets decreased from CNY 364,934,318.44 to CNY 317,715,432.80, representing a reduction of about 12.9%[155]. - The company's total liabilities as of June 30, 2023, were CNY 169,380,466.43, compared to CNY 162,590,241.93 at the start of the year[160]. Investments and Projects - The company has invested 70% in a project to produce 12,000 tons of astaxanthin annually, with a total investment of 100 million RMB[42]. - The company is focusing on expanding its military sector through the capital increase in Hubei Xinrui Optical Technology Co., Ltd., enhancing its competitive edge in the military field[78]. - The company has signed an investment agreement to increase the registered capital of its subsidiary, New Rui Guang, to 40 million yuan[136]. - The company has made strategic investments to enhance its military industry layout through partnerships with You Lian Chang Xin and Shi Fou Feng Ge[136]. Research and Development - The research and development model includes both customer-driven and self-initiated projects to maintain technological leadership in niche markets[38]. - The company has a robust R&D team with expertise in various biological products, contributing to its innovative production techniques in the health sector[53]. - Research and development expenses rose to CNY 1,459,103.08 in the first half of 2023, compared to CNY 666,471.09 in the same period of 2022[163]. Risk Management - The company faces various operational risks, which are detailed in the report, and emphasizes the importance of risk awareness for investors[6]. - The company faces risks from market competition, particularly in composite materials, and plans to increase product development and market expansion efforts[79]. - The company is also addressing risks from natural disasters by improving infrastructure resilience and utilizing new technologies[80]. Corporate Governance and Shareholder Matters - The company plans not to distribute cash dividends or issue bonus shares for the first half of 2023[86]. - The annual shareholders' meeting on June 16, 2023, had a participation rate of 12.23%[84]. - The company has canceled unexercised stock options from the first exercise period of the 2021 stock option incentive plan, totaling 1,925,449 options[94]. - The company appointed a new deputy general manager, replacing the previous one due to personal reasons on June 19, 2023[85]. Market and Competitive Position - The military business segment focuses on high-silicon aluminum alloys and gradient silicon-aluminum composite materials, contributing to advanced radar and aerospace applications[32]. - The agricultural segment aims to stabilize original grain storage and sales while enhancing brand building and product profitability through technological innovation[39]. - The company is actively collaborating with military clients to expand production capacity and meet customer demands in the military sector[33]. Compliance and Legal Matters - The company has not faced any administrative penalties due to environmental issues during the reporting period[100]. - There were no significant lawsuits or arbitration matters during the reporting period[112]. - The company has not engaged in any related party transactions during the reporting period[113].

公司于2023年8月22日召开第九届董事会第五十二次会议，审议通过了《关 于全资子公司购买债权的议案》，根据深圳证券交易所《股票上市规则》和公司 《对外投资管理办法》的相关规定，本次对外投资事项无需提交股东大会审议批 准。 本次交易不构成关联交易，也不构成《上市公司重大资产重组管理办法》规 定的重大资产重组，无需经有关部门批准。 二、交易双方的基本情况 证券代码：000638 证券简称：万方发展 公告编号：2023-032 万方城镇投资发展股份有限公司 关于全资子公司购买债权的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、概述 2023年8月22日，万方城镇投资发展股份有限公司（以下简称"公司"）全资 子公司吉林万方嘉汇企业运营管理有限公司（以下简称"万方嘉汇"或"受让方"） 与北京辉创思宇商贸有限公司（以下简称"辉创思宇"或"出让方"）签订了《债权 转让协议》，万方嘉汇将出资6,400万元，购买辉创思宇持有的对四川三洲川化机 核能设备制造有限公司（以 ...

万方城镇投资发展股份有限公司（以下简称"公司"）第九届董事会第五十二 次会议通知于 2023 年 8 月 18 日以通讯形式发出，会议于 2023 年 8 月 22 日下 午 14：30 时在北京市朝阳区裕民路 12 号中国国际科技会展中心 B 座 12A 公司 会议室以通讯的方式召开，会议应到董事 9 名，实到 9 名，会议由董事长张晖先 生主持，本次会议召开符合《公司法》及《公司章程》的相关规定。会议审议并 通过了如下议案： 一、以9票同意，0票反对，0票弃权，审议通过了《关于全资子公司购买债 权的议案》。 具体内容详见公司同日在《中国证券报》《证券时报》《上海证券报》《证券 日报》及巨潮资讯网（http://www.cninfo.com.cn）披露的《关于全资子公司购买 债权的公告》（公告编号：2023-032）。 证券代码：000638 证券简称：万方发展 公告编号：2023-031 万方城镇投资发展股份有限公司 第九届董事会第五十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露内容的真实、准确、完整 ...

证券代码：000638 证券简称：万方发展 万方城镇投资发展股份有限公司 投资者关系活动记录表 编号：2023-001 2、万方发展主要经营什么？ 您好，目前我公司主要业务包括军工产业、农业产业以及生物健康等 相关业务。感谢您的提问，谢谢。 3、为什么不派发现金红利，不送红股？股民一年等一次分红。 您好，感谢您的提问。根据《公司法》和《公司章程》的相关规定， 公司实现的利润应首先用于弥补以前年度亏损，完全弥补以前年度亏 损后才能进行分配。中兴财光华会计师事务所（特殊普通合伙）审计 确认，公司 2022 年度实现归属于母公司所有者净利润 420.12 万元。 截至 2022 年 12 月 31 日，公司合并期末未分配利润-28,303.51 万元， 而截至 2022 年 12 月 31 日，公司母公司期末未分配利润-29,330.50 万 元。 基于以上情况，公司 2022 年度不进行利润分配，亦不进行资本 公积转增股本。公司管理层及下属子公司将通过努力，积极拓展市 场、扩大经营、加大转型力度，竭尽全力提高公司盈利能力。谢谢。 4、董秘您好，我看了贵公司的年报，非常关注贵公司虾青素产业的 发展，公司的虾青素生产 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 证券代码：000638 证券简称：万方发展 公告编号：2023-016 万方城镇投资发展股份有限公司 关于参加网上集体业绩说明会的公告 董 事 会 二〇二三年五月十二日 1 / 1 特此公告。 万方城镇投资发展股份有限公司 为进一步加强与投资者的互动交流，万方城镇投资发展股份有限公司（以下 简称"公司"）将参加由吉林证监局、吉林省证券业协会、深圳市全景网络有限 公司共同举办的"2023 年吉林辖区上市公司网上集体业绩说明会"，现将有关事 项公告如下： 本次集体业绩说明会将通过深圳市全景网络有限公司提供的互联网平台举 行，投资者可以登陆"全景网"投资者关系互动平台"（http://ir.p5w.net）参与公 司业绩说明会，时间为 2023 年 5 月 22 日（星期一）14:00 至 16:00。 届时公司董事兼总经理章寒晖先生，董事、常务副总经理兼董事会秘书郭子 斌女士，财务总监谌志旺先生将通过网络在线问答互动的形式，与投资者就 2022 年经营业绩等投资者关注的问题进行交流。期间，公司高管将全程在线，实时回 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥36,657,977.24, representing a 27.05% increase compared to ¥28,853,677.06 in the same period last year[5] - The net loss attributable to shareholders was ¥3,679,649.02, a 12.08% improvement from a loss of ¥4,185,069.86 in the previous year[5] - The basic and diluted earnings per share were both -¥0.0119, showing an 11.85% improvement from -¥0.0135 in the previous year[5] - Net loss for Q1 2023 was CNY 4,187,955.96, compared to a net loss of CNY 4,432,439.88 in Q1 2022, showing a slight improvement[23] - The total comprehensive income for the period was -4,232,170.28 yuan, compared to -4,432,439.88 yuan in the previous period, showing an improvement of approximately 4.5%[24] Cash Flow - The net cash flow from operating activities improved by 54.11%, amounting to -¥25,124,379.37 compared to -¥54,751,275.39 in the same period last year[5] - The net cash flow from operating activities was -25,124,379.37 yuan, an improvement from -54,751,275.39 yuan in the previous period, indicating a reduction in cash outflow of about 54.2%[27] - Cash inflow from sales of goods and services was 28,254,354.18 yuan, up from 18,054,927.23 yuan, representing a growth of approximately 56.5%[26] - The net cash flow from investing activities was -1,622,320.00 yuan, compared to -32,747,918.63 yuan in the previous period, reflecting a significant reduction in cash outflow of about 95.0%[27] - The net cash flow from financing activities was 3,699,378.75 yuan, a recovery from -6,458,670.84 yuan in the previous period, indicating a turnaround in financing cash flow[27] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥551,671,427.00, a decrease of 2.79% from ¥567,518,095.85 at the end of the previous year[5] - The company's total assets decreased to CNY 551,671,427.00 from CNY 567,518,095.85 at the beginning of the year, a decline of 2.5%[22] - Current liabilities decreased to CNY 307,041,602.72 from CNY 327,076,355.21, a reduction of 6.1%[22] - The total owner's equity decreased to CNY 224,456,814.85 from CNY 228,358,655.94, a decline of 1.7%[22] Investments and Expenditures - The company's investment income for the period was -¥16,950.00[12] - The cash flow from investing activities was -¥162,230.00, mainly due to the acquisition of long-term assets[14] - The company reported an increase in development expenditures to CNY 1,403,991.69 from CNY 729,467.08, indicating a focus on new product development[22] - Long-term equity investments slightly decreased to CNY 59,917,415.62 from CNY 60,086,942.56, a decline of 0.3%[22] Government Support and Tax - The company received government subsidies amounting to ¥2,216,355.82, primarily from its subsidiary Harbin Zhuding Gongda New Materials Technology Co., Ltd.[7] - The company received 170,612.32 yuan in tax refunds, up from 12,075.27 yuan, indicating a significant increase in tax-related cash inflows[26] Financial Expenses - The company's financial expenses for Q1 2023 were CNY 1,292,801.46, down from CNY 1,490,998.99 in the previous year[23] - The cash outflow for employee compensation was 4,413,716.48 yuan, slightly decreased from 4,710,622.96 yuan in the previous period[27] Consistency in Performance - The company did not report any net profit from merged entities during the current and previous periods, maintaining a consistent performance in this area[24]